Literature DB >> 2908290

Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours.

E Helseth1, G Unsgaard, A Dalen, H Fure, T Skandsen, A Odegaard, R Vik.   

Abstract

Amplification and overexpression of proto-oncogenes are associated with the malignant nature of some human tumours. In this study we have determined the prevalence of amplification of the proto-oncogenes c-erb B1 (= epidermal growth factor receptor gene), c-erb B2 and c-myc in 44 human intracranial tumours (27 gliomas, six metastases to the brain and 11 meningiomas). None of the tumours had an amplified c-erb B2 gene and only two tumours had an amplified c-myc gene. Nineteen per cent (five out of 27) of the gliomas, 50% (three out of six) of the brain metastases and 0% (0 out of 11) meningiomas had an amplified EGF-receptor gene. Amplification of the EGF-receptor gene appeared to give a growth advantage when single-cell suspensions of the tumours were grown in agarose.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2908290     DOI: 10.3109/02688698808992672

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

1.  DNA amplifications and elevated expression of proto-oncogene in addition to altered DNA ploidy in metastatic brain tumors.

Authors:  T Arai; K Ichimura; K Hirakawa; Y Yuasa
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

2.  Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas.

Authors:  S H Torp; E Helseth; A Dalen; G Unsgaard
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance.

Authors:  R A Hawkins; E Killen; I R Whittle; W J Jack; U Chetty; R J Prescott
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.